Tango Therapeutics Inc is a biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TNGX is expected to report earnings to rise 124.57% to -31 cents per share on March 30
Q4'25
Est.
$-0.31
Q3'25
Missed
by $0.07
Q2'25
Est.
$-0.35
Q1'25
Est.
$-0.36
Q4'24
Missed
by $0.01
The last earnings report on November 04 showed earnings per share of -14 cents, missing the estimate of -7 cents. With 1.39M shares outstanding, the current market capitalization sits at 1.03B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TNGX showed earnings on November 04, 2025. You can read more about the earnings report here.